• Title/Summary/Keyword: IIA

Search Result 450, Processing Time 0.255 seconds

Locoregional Spread and Survival of Stage IIA1 versus Stage IIA2 Cervical Cancer

  • Hongladaromp, Waroonsiri;Tantipalakorn, Charuwan;Charoenkwan, Kittipat;Srisomboon, Jatupol
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권2호
    • /
    • pp.887-890
    • /
    • 2014
  • This study was undertaken to compare surgical outcomes and survival rates of patients with the 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIA1 versus IIA2 cervical cancer treated with radical hysterectomy and pelvic lymphadenectomy (RHPL). Patients with stage IIA cervical cancer undergoing primary RHPL between January 2003 and December 2012 at Chiang Mai University Hospital were retrospectively reviewed. The analysis included clinicopathologic variables, i.e. nodal metastasis, parametrial involvement, positive surgical margins, deep stromal invasion (DSI)), lymph-vascular space invasion (LVSI), adjuvant treatment, and 5-year survival. The chi square test, Kaplan-Meier method and log-rank test were used for statistical analysis. During the study period, 133 women with stage IIA cervical cancer, 101 (75.9 %) stage IIA1, and 32 (24.1 %) stage IIA2 underwent RHPL. The clinicopathologic variables of stage IIA1 compared with stage IIA2 were as follows: nodal metastasis (38.6% vs 40.6%, p=0.84), parametrial involvement (10.9% vs 15.6%, p=0.47), positive surgical margins (31.7% vs 31.3%, p=1.0), DSI (39.6% vs 53.1%, p=0.18), LVSI (52.5% vs 71.9%, p=0.05) and adjuvant radiation (72.3% vs 84.4%, p=0.33). With a median follow-up of 60 months, the 5-year disease-free survival (84.6% vs 88.7%, p=0.67) and the 5-year overall survival (83.4% vs 90.0%, P=0.49) did not significantly differ between stage IIA1 and stage IIA2 cervical cancer. In conclusion, patients with stage IIA1 and stage IIA2 cervical cancer have comparable rates of locoregional spread and survival. The need for receiving adjuvant radiation was very high in both substages. The revised 2009 FIGO system did not demonstrate significant survival differences in stage IIA cervical cancer treated with radical hysterectomy. Concurrent chemoradiation should be considered a more suitable treatment for patients with stage IIA cervical cancer.

Inhibitory effects of antithrombin on the expression of secretory group IIA phospholipase A2 in endothelial cells

  • Kim, Tae-Hoon;Bae, Jong-Sup
    • BMB Reports
    • /
    • 제43권9호
    • /
    • pp.604-608
    • /
    • 2010
  • Tumor necrosis factor-$\alpha$ (TNF-$\alpha$) mediates proinflammatory responses in primary human umbilical vein endothelial cells (HUVECs), and it upregulates the expression of secretory group IIA phospholipase $A_2$ ($sPLA_2$-IIA). $sPLA_2$-IIA plays a pivotal role in inflammation, and antithrombin (AT) possesses properties that are beneficial to endothelial cells. Therefore, we investigated the effects of AT on the expression of $sPLA_2$-IIA in TNF-$\alpha$-stimulated HUVECs. TNF-$\alpha$ potently upregulated the expression of $sPLA_2$-IIA, and prior treatment of cells with AT inhibited the expression of $sPLA_2$-IIA in HUVECs. Also, antibodies or siRNA for syndecan-4 blocked the protective effect of AT. Furthermore, PI3-kinase and the AKT pathway are significantly involved in the AT-mediated inhibition of the expression of $sPLA_2$-IIA. These results show that AT effectively suppresses the upregulated $sPLA_2$-IIA expression, which might contribute to the cytoprotective effects of AT in the treatment of severe inflammatory diseases.

Tanshinone IIA Protects Endothelial Cells from H2O2-Induced Injuries via PXR Activation

  • Zhu, Haiyan;Chen, Zhiwu;Ma, Zengchun;Tan, Hongling;Xiao, Chengrong;Tang, Xianglin;Zhang, Boli;Wang, Yuguang;Gao, Yue
    • Biomolecules & Therapeutics
    • /
    • 제25권6호
    • /
    • pp.599-608
    • /
    • 2017
  • Tanshinone IIA (Tan IIA) is a pharmacologically active substance extracted from the rhizome of Salvia miltiorrhiza Bunge (also known as the Chinese herb Danshen), and is widely used to treat atherosclerosis. The pregnane X receptor (PXR) is a nuclear receptor that is a key regulator of xenobiotic and endobiotic detoxification. Tan IIA is an efficacious PXR agonist that has a potential protective effect on endothelial injuries induced by xenobiotics and endobiotics via PXR activation. Previously numerous studies have demonstrated the possible effects of Tan IIA on human umbilical vein endothelial cells, but the further mechanism for its exerts the protective effect is not well established. To study the protective effects of Tan IIA against hydrogen peroxide ($H_2O_2$) in human umbilical vein endothelial cells (HUVECs), we pretreated cells with or without different concentrations of Tan IIA for 24 h, then exposed the cells to $400{\mu}M$ $H_2O_2$ for another 3 h. Therefore, our data strongly suggests that Tan IIA may lead to increased regeneration of glutathione (GSH) from the glutathione disulfide (GSSG) produced during the GSH peroxidase-catalyzed decomposition of $H_2O_2$ in HUVECs, and the PXR plays a significant role in this process. Tan IIA may also exert protective effects against $H_2O_2$-induced apoptosis through the mitochondrial apoptosis pathway associated with the participation of PXR. Tan IIA protected HUVECs from inflammatory mediators triggered by $H_2O_2$ via PXR activation. In conclusion, Tan IIA protected HUVECs against $H_2O_2$-induced cell injury through PXR-dependent mechanisms.

Oxidized LDL induces phosphorylation of non-muscle myosin IIA heavy chain in macrophages

  • Park, Young Mi
    • BMB Reports
    • /
    • 제48권1호
    • /
    • pp.48-53
    • /
    • 2015
  • Oxidized LDL (oxLDL) performs critical roles in atherosclerosis by inducing macrophage foam cell formation and promoting inflammation. There have been reports showing that oxLDL modulates macrophage cytoskeletal functions for oxLDL uptake and trapping, however, the precise mechanism has not been clearly elucidated. Our study examined the effect of oxLDL on non-muscle myosin heavy chain IIA (MHC-IIA) in macrophages. We demonstrated that oxLDL induces phosphorylation of MHC-IIA (Ser1917) in peritoneal macrophages from wild-type mice and THP-1, a human monocytic cell line, but not in macrophages deficient for CD36, a scavenger receptor for oxLDL. Protein kinase C (PKC) inhibitor-treated macrophages did not undergo the oxLDL-induced MHC-IIA phosphorylation. Our immunoprecipitation revealed that oxLDL increased physical association between PKC and MHC-IIA, supporting the role of PKC in this process. We conclude that oxLDL via CD36 induces PKC-mediated MHC-IIA (Ser1917) phosphorylation and this may affect oxLDL-induced functions of macrophages involved in atherosclerosis.

폴리히드라존계 킬레이트 고분자의 합성과 특성 (Synthesis and Characterization of Chelated Polymers of Polyhydrazones)

  • 김공수;이영우;이두희
    • 대한화학회지
    • /
    • 제29권5호
    • /
    • pp.543-551
    • /
    • 1985
  • $p^-$, $m^-$, o-phthalaldehyde 및 5,5'-methylene-bis-salicyl aldehyde (PPTA, MPTA, OPTA, MBSA)와 5,5'-methylene-bis-salicylic dihydrazide, terephthalic dihydrazide 및 sebacic dihydrazide(MBSDH, TDH 및 SDH)등의 디히드라지드 화합물을 DMF-$CH_3COOH$ 혼합용액 중에서 축합반응으로 몇가지 새로운 폴리히드라존을 합성하였다. 합성한 폴리히드라존과 그의 금속킬레이트의 용해성, 흡수스펙트라 및 열적성질에 대하여 검토하였다. OPTA와 MBSDH의 반응으로 얻어진 폴리히드라존을 제외한 폴리히드라존과 그의 금속킬레이트는 일반적으로 보통 유기용매에 불응성이었다. 폴리히드라존의 중량열분석 결과 250-350$^{\circ}$C 사이에서 10%의 중량감소가 일어났고 500$^{\circ}$C고 500 폴리히드라존의 중량열분석 결과 250~350$^{\circ}$C 사이에서 10%의 중량감소가 일어났고 500$^{\circ}$C에서 32.5~63.5% 범위의 잔유중량을 나타내었다. 합성한 폴리히드라존 중에서 PPTA-MBSDH(IIa)및 MBSA-MBSDH(IIIa)가 열분해온도가 비교적 높았으며 IIa의 금속킬레이트에 있어서는 Zn(II)-IIa>Ni(II)-IIa>Co(II)-IIa>Cu(II)-IIa의 순서로 열분해온도가 저하되었다.

  • PDF

단삼 유래 Tanshinone IIA가 3T3-L1 세포의 아포토시스 유도와 지방형성 억제에 미치는 영향 (Effects of Tanshinone IIA from Salvia Miltiorrhiza Bunge on Induction of Apoptosis and Inhibition of Adipogenesis in 3T3-L1 Cells)

  • 정승일;이종우;장선일
    • 동의생리병리학회지
    • /
    • 제23권6호
    • /
    • pp.1409-1415
    • /
    • 2009
  • Obesity is especially a serious health problem in industrialized countries, because it is considered to be a risk factor associated with the genesis or development of various metabolic diseases, including cardiovascular disease and type 2 diabetes mellitus. The purpose of this study was to investigate the effects of tanshinone IIA from Salvia miltiorrhiza Bunge on induction of apoptossis and inhibition of adipogenesis in in 3T3-L1 preadipocytes and adipocytes. The results demonstrated that tanshinone IIA decreased cell population growth of 3T3-L1 preadipocytes, assessed with the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] and LDH (lactate dehydrogenase) assay. Flow cytometric analysis of 3T3-L1 preadipocytes exposed to tanshinone IIA showed that apoptotic cells increased in a timeand dose-dependent manner. Treatment with tanshinone IIA decreased the number of normal cells and increased the number of apoptotic cells in a dose-dependent manner. The induction of apoptosis in 3T3-L1 preadipocytes by tanshinone IIA was mediated through the activation of caspase-3 and Bax, and then through the cleavage of PARP and the down-regulation of Bcl-2. Moreover, tanshinone IIA significantly decreased the amount of intracellular triglycerides and GPDH (glycerol-3-phosphate dehydrogenase) activity in 3T3-L1 adipocytes. Our results suggest that tanshinone IIA efficiently induces apoptosis and inhibits adipogenesis in 3T3-L1 preadipocytes and adipocytes.

Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B5, a Mucosal Adjuvant Derived from a Type II Heat-Labile Enterotoxin of Escherichia coli

  • Lee, Chang Hoon;Hajishengallis, George;Connell, Terry D.
    • Journal of Microbiology and Biotechnology
    • /
    • 제27권4호
    • /
    • pp.709-717
    • /
    • 2017
  • Mucosal tissues are the initial site through which most pathogens invade. As such, vaccines and adjuvants that modulate mucosal immune functions have emerged as important agents for disease prevention. Herein, we investigated the immunomodulatory mechanisms of the B subunit of Escherichia coli heat-labile enterotoxin type IIa ($LT-IIa-B_5$), a potent non-toxic mucosal adjuvant. Alternations in gene expression in response to $LT-IIa-B_5$ were identified using a genome-wide transcriptional microarray that focused on dendritic cells (DC), a type of cell that broadly orchestrates adaptive and innate immune responses. We found that $LT-IIa-B_5$ enhanced the homing capacity of DC into the lymph nodes and selectively regulated transcription of pro-inflammatory cytokines, chemokines, and cytokine receptors. These data are consistent with a model in which directional activation and differentiation of immune cells by $LT-IIa-B_5$ serve as a critical mechanism whereby this potent adjuvant amplifies mucosal immunity to co-administered antigens.

공항 및 공역관리 제도 개선에 관한 연구 (A Study on the Airport and Airspace Management)

  • 김병종;양한모
    • 항공우주정책ㆍ법학회지
    • /
    • 제12권
    • /
    • pp.246-274
    • /
    • 2000
  • This paper discusses the qualification criteria for international hub airport and suggests the strategies for Inchon International Airport (IIA) to be the hub airport in the East Asia. Recently, many East and Southeast Asia countries have invested on large scale international airports like Chap Lak Kok airport, Pudong airport etc.. as Korea have done on IIA. IIA to be open in 2001 will face a serious competition with these airport. Being a hub airport requires geographic proximity. sufficient volume of local traffic. uncongested infrastructure, a good accessibility to surrounding industrial centers. high quality of service to the airline. In order to promote airlines to land at IIA. Korea Government need to establish Open Sky Policy to many countries and national flag carriers of Korea need to be involved in a global alliance. Developing vicinity of IIA as free trade zone will generated more local traffic which makes IIA as more attractive candidate for airlines. The Korea airspace is one of the most restricted area in the world becuase of the national security. which limits civil aircraft maneuvers. The airspace need to be re-structured to exploit the full capacity of IIA.

  • PDF

병기 IIa, IIb 자궁경부암에서 방사선치료와 Hydroxyurea 병합치료 결과 (Hydroxyurea with Radiation Therapy of the Carcinoma of the Cervix IIA, IIB)

  • 김진희;윤선민;김옥배
    • Radiation Oncology Journal
    • /
    • 제13권4호
    • /
    • pp.369-375
    • /
    • 1995
  • 목적 : 종양의 크기가 큰 외장성 이나 내장성의 병기 IIa, IIb 자궁경부암 환자에서 방사선치료와 hydroxyurea 동시병합치료의 효과에 대한 후향적 연구를 시행하였다. 방법 : 1989년 8월부터 1991년 5월까지 계명대학교 동산의료원 치료방사선과에서 방사선치료와 방사선 감작제로 hydroxyurea 병합치료를 받은 종양의 크기가 3cm 이상인 외장성이나 재장성의 병기 IIa, IIb 자궁경부암환자 64명을 대상으로 하였다. 병기 IIa가 29명, 병기 IIb가 35명이었고 평균연령은 53.8세이었다. 최장기 및 평균 추적기간은 각각 68개월, 57개원이었다. 방사선치료는 외부방사선치료로 전골반강에 하루에 180cGy로 분할하여 3600-5400 cGy 조사하고 양편자궁주위에 조사량이 4500-6300 cGy 되도록 $4{\times}10cm$ 중간차폐를 하여 조사한 후 강내조사를 하였다(전체 조사량이 A 지점에 7100-7500cGy). Hydroxyurea는 방사선치료를 하는동안 1.0gm/day 1회 경구투약 하였다. 결과 : 완전관해율은 89.1%, 5년생존율은 병기 IIa에서 78.8%, 병기 IIb에서 72.8% 이었고 전체 재발률은 25% (16/64) 이었다. 23%에서 3도이상의 백혈구 감소증을 보였고 4%에서 3도이상의 혈소판감소증을 보였으나 자연적으로 회복되었고 3도이상의 빈혈, 위장관계 및 비뇨생식계 합병증은 없었고 치료에의한 사망은 없었다. 결론 : 위와 같은 결과로 볼때 종양의 크기가 큰 외장성 또는 내장성의 병기 IIa 자궁경부암에서 방사선치료과 방사선 감작제로써 hydroxyurea의 병용은 심각한 합병증 없이 생존률을 향상시킬 수 있을것으로 사료된다.

  • PDF

단삼(Salvia miltiorrhiza Bunge)으로 부터 Tanshinone IIA의 분리 및 함량분석 (Isolation and Quantitative Determination of Tanshinone IIA from the Rhizomes of Salvia miltiorrhiza Bunge)

  • 박미정;이승호;박정일;강신정;장승엽;이경순;손건호
    • 생약학회지
    • /
    • 제30권2호
    • /
    • pp.158-162
    • /
    • 1999
  • The rhizomes of Salvia miltiorrhiza Bunge(Labiatae) has been used in Chinese traditional medicine for the treatment of coronary heart diseases and myocardial infarction. As a part of a research for standardization of crude oriental drugs, we have determined the content of tanshinone IIA in Salvia miltiorrhiza purchased from various regions of Korea. The HPLC method by which quantitative analysis was conducted, showed reproducible results and chromatographic isolation of tanshinone IIA was accomplished successively.

  • PDF